CrossRef Text and Data Mining
Result of CrossRef Text and Data Mining Search is the related articles with entitled article. If you click link1 or link2 you will be able to reach the full text site of selected articles; however, some links do not show the full text immediately at now. If you click CrossRef Text and Data Mining Download icon, you will be able to get whole list of articles from literature included in CrossRef Text and Data Mining.
High-Dose Chemotherapy of Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) Followed by Autologous Stem-Cell Transplantation for Metastatic Breast Cancer Patients: A 6-Year Follow-Up Result
Hee-Jung Sohn, Sang-Hee Kim, Gyeong-Won Lee, Shin Kim, Hye Jin Kang, Jin-Hee Ahn, Sung-Bae Kim, Sang-We Kim, Woo Kun Kim, Cheolwon Suh
Cancer Research and Treatment. 2005;37(1):24-30.   Published online 2005 February 28    DOI: https://doi.org/10.4143/crt.2005.37.1.24

Excel Download

High-Dose Chemotherapy of Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) Followed by Autologous Stem-Cell Transplantation for Metastatic Breast Cancer Patients: A 6-Year Follow-Up Result
Cancer Research and Treatment. 2005;37(1):24   Crossref logo
Link1 Link2

High-Dose Chemotherapy of Cyclophosphamide, Thiotepa and Carboplatin (CTCb) followed by Autologous Stem-Cell Transplantation as a Consolidation for Breast Cancer Patients with 10 or more Positive Lymph Nodes: a 5-Year follow-Up Results
Cancer Research and Treatment. 2005;37(3):137   Crossref logo
Link1 Link2

CD34+ Cell Dose Requirements for Rapid Engraftment in a Sequential High-Dose Chemotherapy Regimen of Paclitaxel, Melphalan, and Cyclophosphamide, Thiotepa, and Carboplatin (CTCb) with PBPC Support in Metastatic Breast Cancer
Journal of Hematotherapy & Stem Cell Research. 1999;8(4):357-363   Crossref logo
Link1

Epirubicin-containing high-dose chemotherapy followed by autologous hematopoietic progenitor cell transfusion for patients with chemotherapy-sensitive metastatic breast cancer: results of 5-year follow-up
Cancer Chemotherapy and Pharmacology. 1999;43(1):8-12   Crossref logo
Link1 Link2 Link3

ototoxicity after high-dose chemotherapy with cyclophosphamide, thiotepa and carboplatin followed by stem cell transplantation in patients with breast cancer
Medical Oncology. 2000;17(4):287-292   Crossref logo
Link1 Link2 Link3

Phase II study of high-dose cyclophosphamide, etoposide, and carboplatin (CEC) followed by autologous hematopoietic stem cell rescue in women with metastatic or high-risk non-metastatic breast cancer: multivariate analysis of factors affecting survival and engraftment
Bone Marrow Transplantation. 1997;20(4):273-281   Crossref logo
Link1 Link2 Link3

High dose chemotherapy (HDCT) with mitoxantrone, cyclophosphamide, vinblastine or carboplatin with bone marrow support in metastatic breast cancer (MBC): Role of autologous peripheral blood stem cell transplantation (PBSCT) and cytokines
European Journal of Cancer. 1993;29:S83   Crossref logo
Link1 Link2

Double high-dose chemotherapy with adriamycin, paclitaxel, cyclophosphamide, and thiotepa followed by autologous peripheral blood stem cell transplantation in women with metastatic breast cancer
Journal of Cancer Research and Clinical Oncology. 2003;129(6):361-366   Crossref logo
Link1 Link2 Link3

High-dose cyclophosphamide + carboplatin and interleukin-2 (IL-2) activated autologous stem cell transplantation followed by maintenance IL-2 therapy in metastatic breast carcinoma – a phase II study
Bone Marrow Transplantation. 2000;25(1):19-24   Crossref logo
Link1 Link2 Link3

473 PUBLICATION High-dose chemotherapy and autologous peripheral blood stem cell transplantation in metastatic breast cancer. updated results of a single center
European Journal of Cancer Supplements. 2005;3(2):132   Crossref logo
Link1 Link2

This metadata service is kindly provided by CrossRef from May 29, 2014. Cancer Res Treat has participated in CrossRef Text and Data Mining service since October 29, 2014.